Inspection Record

Diteba Inc. — Health Canada Inspection Findings

Health CanadaInspected 2025-08-19 5 findingsLaboratory and QC controlsDeviation, CAPA, and investigationEquipment and facilityMaterial and supplier control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

The creation, maintenance, processing, and/or review of laboratory data was inadequate. The validation and/or the documentation of test methods was inadequate.

2Laboratory and QC controls

The design, equipment, and/or maintenance of the testing laboratory was inadequate. The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

3Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

4Equipment and facility

The maintenance of records was inadequate.

5Material and supplier control

The handling and/or storage of samples was inadequate for raw materials, drugs being processed, bulk drugs, and/or finished products.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-08-19. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Diteba Inc. company profile — full history Health Canada documents, 2025 Go to Findings search